Olympus-backed PAI Pharma acquires Nexus Pharmaceuticals
Nexus Pharmaceuticals, a U.S. specialty pharmaceutical company making complex injectable medicines, adds more than 20 hospital injectable products to PAI Pharma.
Most recent deal Thursday, November 12, 2026.
Platforms: PAI Pharma (1 add-on)
Nexus Pharmaceuticals, a U.S. specialty pharmaceutical company making complex injectable medicines, adds more than 20 hospital injectable products to PAI Pharma.
MEI provides rigging, industrial storage and equipment installation services from 30 locations, with nearly 2,500 employees across the United States.